Interaction of 5-chloro-1-phenyl-1H-pyrazole-4-carboxamide and 5-chloro-N-formyl-1-phenyl-1H-pyrazole-4-carboxamide with hydrazine hydrate
DOI:
https://doi.org/10.24959/ophcj.14.759Keywords:
pyrazole, pyrazole-4-carboxamide, pyrazole-4-carbohydrazide, hydrazine hydrateAbstract
This article represents the research of the interaction of 1-phenyl-5-chloro-1H-pyrazole-4-carboxamide and 1-phenyl-N-formyl-5-chloro-1H-pyrazole-4-carboxamide with hydrazine hydrate in order to get pyrazole derivatives as potential bioactive substances. It has been found that during the short (~40 min) boiling of 1-phenyl-5-chloro-1H-pyrazole-4-carboxamide with hydrazine hydrate a previously unknown 5-hydrazino-1-phenyl-1Hpyrazole-4-carbohydrazide with the yield of 50% is formed. The further boiling (~15 h) of the product obtained with hydrazine hydrate leads unexpectedly to 1-phenyl-1H-pyrazole-4-carbohydrazide. The probable mechanism of its obtaining, which includes dimerization of the prototropic isomer formed while cleaving the hydrazine molecule and the further elimination of the nitrogen molecule, has been considered. When boiling with hydrazine hydrate for 3 hours 1-Phenyl-N-formyl-5-chloro-1H-pyrazole-4-carboxamide gives 5-amino-1-phenyl-1H-pyrazole-4-carbohydrazide. At first, obviously, N-[(5-hydrazino-1-phenyl-1H-pyrazol-4-yl) carbonyl]formamide is formed with further cyclization into pyrazole[3,4-d][1,2,3]triazin-4-one. The latter eliminates the nitrogen molecule when heating with the formation of the reactive 4-carbonyl-1-phenyl-4,5-dihydro-1H-pyrazole-5-imine. Addition of hydrazine to it leads to 5-amino-1-phenyl-1H-pyrazole-4-carbohydrazide. The composition of all compounds synthesized has been proven by elemental analysis and the structure has been confirmed by spectroscopic methods.
Downloads
References
- Khytova B. M., Klyuchko S. V., Gurenko A. O. еt al. Khimija geterociklicheskikh soedinemijj – Chem. Heterocycl. compd., 2013, No.6, pp.987-998.
- Vovk M. V., Bratenko М. К., Chornous V. A. 4-Funkcionalizirovannye pirazoly (4-functionalized pyrazoles), Chernovcy, Prut, 2008, 278 p.
- Bezuglyj P. О. Farmacevticheskaja khimija – Pharmaceutical chemistry, Vinnica, Novaja kniga, 2006, 315 p.
- Hall A., Billinton A., Bristow A. K. et al. Bioorg. Med. Chem. Lett., 2008, Vol. 18, pp.4027-4032.
- Rapposelli S., Lapucci A., Minutolo F. et al. IL Farmaco, 2004, Vol. 59, pp.25-31.
- Varnes J. G., Wacker D. A., Jacobson I. C. et al. Bioorg. Med. Chem. Lett., 2007, Vol. 17, pp.6481-6488.
- Bekhit A. A., Ashour H. M., Abdel Ghany Y. S. et al. Eur. J. Med. Chem., 2008, Vol. 43, pp.456-463.
- Padmaja A., Payani T., Reddy G. D., Padmavathi V. Eur. J. Med. Chem., 2009, Vol. 44, pp.4557-4566.
- Ragavan R. V., Vijayakumar V., Kumari N. S. Eur. J. Med. Chem., 2010, Vol. 45, pp.1173-1180.
- Riyadh S. M., Farghaly T. A., Abdallah M. A. et al. Eur. J. Med. Chem., 2010, Vol. 45, pp.1042-1050.
- El-borai M. A., Rizk H. F., Abd-Aal M. F., El-Deeb I. Y. Eur. J. Med. Chem., 2012, Vol. 48. pp.92-96.
- Vujasinovic I., Paravic-Radicevic A., Mlinaric-Majerski K. et al. Bioorg. Med. Chem., 2012, Vol. 20, pp.2101-2110.
- Staudinger H., Kupfer O. Chem. Ber., 1911, Bd. 44, pp.2197-2212.
- Hernandez P., Cabrera M., Lavaggi M. L. et al. Bioorg. Med. Chem., 2012, Vol. 20, pp.2158-2171.
- Hernandez P., Rojas R., Gilman R. H. et al. Eur. J. Med. Chem., 2013, Vol. 59, pp.64-74.
- Dornow A., Hinz E. Chem. Ber., 1958, Bd. 91, pp.1834-1840.
- Wamhoff H., Ertas M., Atta S. M. S. Liebigs Ann. Chem., 1985, No.9, pp.1910-1916.
- Li J.-F., Zhu Y.-Q., Wang X., Yang H.-Z. J. Heterocycl. Chem., 2007, Vol. 44, pp.749-755.
- Khytova B. M., Klyuchko S. V., Gurenko A. O., Vasilenko A. N, Balja A.G., Rusanov Eh. B., Brovarets V. S. Khimija geterociklicheskikh soedinemijj – Chem. Heterocycl. compd., 2012, No.8, pp.1344-1355.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).